Autoantibodies and thrombophilia in RA: TNFα and TNFα blockers

Por Ferraccioli, G, Gremese, E
Publicado em 2004

B cell activating factor (BAFF) and BAFF receptors: fakes and facts

Por Ferraccioli, G., Gremese, E.
Publicado no Clin Exp Immunol (2017)

Platelet GPIIb/IIIa (P1A(1/2)) polymorphism in SLE: clinical and laboratory association

Por Tolusso, B, Fabris, M, Gremese, E, Mosca, M, Rovere-Querini, P, Ferraccioli, G
Publicado em 2003

Driving chronicity in rheumatoid arthritis: perpetuating role of myeloid cells

Por Alivernini, S., Tolusso, B., Ferraccioli, G., Gremese, E., Kurowska‐Stolarska, M., McInnes, I. B.
Publicado no Clin Exp Immunol (2018)

The role of high‐mobility group box protein 1 in collagen antibody‐induced arthritis is dependent on vascular endothelial growth factor

Por Biscetti, F., Flex, A., Pecorini, G., Angelini, F., Arena, V., Stigliano, E., Gremese, E., Tolusso, B., Ferraccioli, G.
Publicado no Clin Exp Immunol (2016)

Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis

Por Tolusso, B, Frezza, D, Mattioli, C, Fedele, A L, Bosello, S, Faustini, F, Peluso, G, Giambra, V, Pietrapertosa, D, Morelli, A, Gremese, E, De Santis, M, Ferraccioli, G F
Publicado em 2008